Project Studie CA209-429

Basic data

Title:
Studie CA209-429
Duration:
15/08/2016 to 31/12/2018
Abstract / short description:
Studie CA209-429: An Open Label Phase Il Study to Evaluate Safety and Efficacy of Combined Treat-ment with Ipilimumab and Nivolumab in Patients with Up to Five Brain Metastases of Melanoma-BRAINIP-Trial
Keywords:
melanoma
Melanom
Brain Metastases

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Tampouri, Ioanna
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Lomberg, Diana
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Spänkuch, Iris
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

München, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.